Cost-Effectiveness Analysis of Desloratadine and Mizolastine in Treatment of Chronic Idiopathic Urticaria
- VernacularTitle:地氯雷他啶与咪唑斯汀治疗慢性特发性荨麻疹的成本-效果分析
- Author:
Qiang LIANG
;
Enrang LIU
;
Qian XIE
- Publication Type:Journal Article
- Keywords:
Chronic idiopathic urticaria;
Desloratadine;
Mizoslatine;
Cost-effectiveness analysis
- From:
China Pharmacy
2001;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05).The C/E were0.456and0.622,respectively.?C/?E was15.9.CONCLUSIONS:Deslo-ratadine has pharmacoeconomical advantages over mizolastine in treating chronic idiopathic urticaria.
